Respiratory Therapy: Sleep-Disordered Breathing

Sleep-disordered breathing (SDB) is a pervasive public health issue that directly impacts cardiorespiratory function and overall quality of life. As a respiratory therapist, you are on the front lines of diagnosing, managing, and counseling patients with these conditions, making your expertise critical for improving patient outcomes. Mastering this area requires a blend of technical skill in device management and a deep understanding of the underlying pathophysiology and its systemic consequences.

Defining the Spectrum of Sleep-Disordered Breathing

At its core, sleep-disordered breathing is an umbrella term for chronic conditions characterized by abnormal respiratory patterns during sleep. The most prevalent and clinically significant forms are obstructive sleep apnea and central sleep apnea. Obstructive sleep apnea (OSA) occurs when the muscles in the back of the throat fail to keep the airway open despite continued effort to breathe. Imagine a floppy hose that collapses when suction is applied; this is analogous to the upper airway during an obstructive event. In contrast, central sleep apnea (CSA) is a disorder of the central nervous system where the brain temporarily fails to send the signal to the muscles that control breathing. There is no respiratory effort, distinguishing it from OSA. Many patients exhibit complex sleep apnea, which is the emergence or persistence of central apneas during treatment for obstructive sleep apnea with positive airway pressure.

The consequences of untreated SDB are profound. Repetitive apneas (cessations of breathing) and hypopneas (shallow breaths) lead to cyclical desaturation, where blood oxygen levels drop, and arousals, where the brain partially wakes to restart breathing. This cycle places immense strain on the cardiovascular system, significantly increasing the risk of systemic hypertension, pulmonary hypertension, heart failure, arrhythmias like atrial fibrillation, and stroke. Furthermore, the fragmented sleep architecture leads to excessive daytime sleepiness, neurocognitive impairment, and reduced quality of life.

The Diagnostic Foundation: Polysomnography Interpretation

The gold standard for diagnosis is an in-lab polysomnography (PSG) study. You must be adept at interpreting its key metrics. The study records brain waves (EEG), eye movements (EOG), muscle activity (EMG), heart rhythm (ECG), airflow, respiratory effort, and oxygen saturation. From this data, several indices are calculated. The Apnea-Hypopnea Index (AHI) is the number of apneas and hypopneas per hour of sleep. An AHI of 5-15 indicates mild sleep apnea, 15-30 is moderate, and >30 is severe. The Respiratory Effort-Related Arousal (RERA) Index measures more subtle airflow limitations that cause arousal, and when combined with the AHI, forms the Respiratory Disturbance Index (RDI). Accurate scoring of these events—distinguishing between obstructive, central, and mixed apneas based on the presence or absence of respiratory effort—is fundamental to guiding appropriate therapy.

Positive Airway Pressure: CPAP and BiPAP Titration

The first-line treatment for moderate to severe OSA is Positive Airway Pressure (PAP) therapy. Your role in titrating this therapy during a split-night or full PAP study is a critical skill. Continuous Positive Airway Pressure (CPAP) delivers a single, constant pressure that acts as a pneumatic splint to keep the upper airway open. The goal of titration is to find the optimal pressure that eliminates obstructive events, snoring, and desaturations across all sleep stages and body positions.

Bilevel Positive Airway Pressure (BiPAP or BPAP) provides two distinct pressures: a higher Inspiratory Positive Airway Pressure (IPAP) and a lower Expiratory Positive Airway Pressure (EPAP). This mode is indicated for patients who require high pressures and have difficulty exhaling against CPAP, those with hypoventilation syndromes (evidenced by elevated carbon dioxide levels), or certain cases of central/complex sleep apnea. The titration process for BiPAP involves independently adjusting the IPAP and EPAP to achieve ventilatory goals. For patients with CSA or complex apnea, advanced devices with a backup rate or adaptive servo-ventilation (ASV) may be employed, though patient selection is crucial, particularly in patients with heart failure.

The Human Element: Mask Fitting and Adherence Counseling

The most perfectly titrated PAP therapy is useless if the patient cannot or will not use it. Mask fitting is therefore one of your most practical and impactful responsibilities. You must assess the patient’s facial anatomy, breathing pattern (nasal vs. mouth), and personal preferences. The three main interfaces are nasal masks, nasal pillows, and full-face masks. A proper fit minimizes leak without causing pressure sores or discomfort. Educating the patient on how to adjust the headgear and use mask liners is key.

Adherence counseling is an ongoing process. Common barriers include discomfort from pressure, claustrophobia, nasal congestion, and dryness. Your toolkit for addressing these includes demonstrating ramp features, explaining the purpose of therapy, recommending heated humidification, and managing nasal symptoms with saline sprays. Reviewing objective adherence data (typically showing usage hours and leak rates) allows for targeted problem-solving. Framing PAP use as essential medication for cardiovascular health, rather than just a sleep aid, can improve long-term compliance.

Adjunctive and Alternative Therapies

While PAP is the cornerstone, a comprehensive approach includes other options. Oral appliance therapy, provided by a dental specialist, involves a mandibular advancement device that physically pulls the lower jaw and tongue forward to enlarge the airway. It is a first-line option for mild to moderate OSA and for patients who are CPAP-intolerant. You should understand its indications and limitations, such as potential for jaw discomfort or dental changes.

Surgical referral criteria are important to recognize. While PAP therapy is the primary treatment, surgery may be considered for patients with specific, correctable anatomical abnormalities (e.g., severe deviated septum, enlarged tonsils) or those who have failed all other therapies. Common procedures include uvulopalatopharyngoplasty (UPPP), maxillomandibular advancement, and hypoglossal nerve stimulation. Your role involves identifying patients who may benefit from an otolaryngology or sleep surgery consultation.

Common Pitfalls

1. Neglecting the Mask Fit: Focusing solely on the machine settings and ignoring patient comfort with the interface is a major error. A high leak rate due to a poor fit will render any pressure setting ineffective and cause therapy failure. Correction: Always conduct a mask fitting session with the patient awake, having them lie in multiple positions to check for seal integrity before finalizing pressure.

1. Misinterpreting the AHI: Assuming a low AHI on a PAP machine's display always indicates successful therapy is a trap. A low AHI with a persistently high leak rate means the data is unreliable; the machine cannot accurately score events amidst large leaks. Correction: Always review both the AHI and the leak data simultaneously to get a true picture of therapy efficacy.

1. Overlooking Comorbidities: Treating the sleep apnea in isolation without addressing contributing factors. Conditions like congestive heart failure, hypothyroidism, and obesity hypoventilation syndrome can exacerbate or even cause SDB. Correction: Maintain a holistic view of the patient. Ensure weight management, heart failure optimization, and other medical therapies are part of the coordinated care plan.

1. Inadequate Follow-Up: Assuming the job is done after the initial setup. PAP therapy requires long-term management. Correction: Schedule systematic follow-ups (e.g., at 1 week, 1 month, and annually) to download device data, address new problems, reinforce education, and re-motivate the patient.

Summary

• Sleep-disordered breathing, primarily obstructive and central sleep apnea, is a serious condition diagnosed via polysomnography, with severity graded by the Apnea-Hypopnea Index (AHI).
• First-line treatment involves Positive Airway Pressure therapy, with CPAP for standard OSA and BiPAP for patients requiring ventilatory support or having difficulty tolerating high CPAP pressures.
• Successful therapy hinges on two clinical skills: a perfect mask fitting to ensure a seal without discomfort, and proactive adherence counseling to overcome common barriers to long-term use.
• Adjunctive treatments include oral appliance therapy for mild-moderate OSA and referral for surgery based on specific anatomical criteria.
• Untreated sleep apnea is a major modifiable risk factor for hypertension, heart failure, stroke, and arrhythmias, while effective treatment significantly improves cardiovascular outcomes and daytime functioning.